A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
Bristol-Myers Squibb
Iovance Biotherapeutics, Inc.
ImmunityBio, Inc.
Eucure (Beijing) Biopharma Co., Ltd
Immodulon Therapeutics Ltd
Seagen Inc.
Eli Lilly and Company
Celgene
Celgene